According to filings with the U.S. Securities and Exchange Commission, Egg Medical is raising up to $9,542,004.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Egg Medical
At EGG Medical we noticed a big gap in the radiation protection for operators, staff and trainees in the cardiac cath labs. Radiation shielding even in state of the art labs is sub-optimal and to date only focuses on the primary operator. This led to the creation of the Egg Medical concept of radiation protection for all? Just like the egg shell protects the growing chick from all external hazards. Egg Medical will be launching its first product, The EGG Nest, for the cardiac cath lab. We have been able to reduce radiation exposure due to scatter by more than 90%.

To learn more about Egg Medical, visit http://eggmedical.com/
Egg Medical Linkedin Page: https://www.linkedin.com/company/egg-medical/

Contact:
Robert Wilson, President and Chief Executive Officer
612-916-6616
https://www.linkedin.com/in/robert-wilson-a90b002/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.